the value of overseas sales, and for new products obtained in Pfizer's recent purchase of specialty drugmaker King Pharmaceuticals. Many investors fear Pfizer, which has bought three of the largest U.S. drugmakers over the past decade, will be far too...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer Profit Tops Forecast, but Revenue Falls Short
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account